Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children

Pediatric Neurosurgery

Volumn 45, Issue 5, 2009, Pages 325-336

  Prusseit, Julia ^a   Simon, Matthias ^b   Von Der Brelie, Christian ^b   Heep, Axel ^a   Molitor, Ernst ^a   Völz, Sebastian ^b   Simon, Arne ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Neurosurgery ^*

Author keywords

Hydrocephalus; Shunt infection; Ventriculoperitoneal shunt

Indexed keywords

AMIKACIN; AMPHOTERICIN B; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; FLUCLOXACILLIN; FOSFOMYCIN; GENTAMICIN; MEROPENEM; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ADJUVANT THERAPY; ANTIBIOTIC PROPHYLAXIS; BACTERIAL VIRULENCE; BRAIN VENTRICLE PERITONEUM SHUNT; CHILD; DIAGNOSTIC PROCEDURE; HUMAN; HYDROCEPHALUS; LATENT PERIOD; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SHUNT INFECTION; SYMPTOM; TREATMENT DURATION;

CHILD; HUMANS; HYDROCEPHALUS; INCIDENCE; PROSTHESIS-RELATED INFECTIONS; RISK FACTORS; VENTRICULOPERITONEAL SHUNT;

EID: 70449512982     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000257520     Document Type: Review

References (124)

1. Turgut M, et al: Cerebrospinal fluid shunt infections in children. Pediatr Neurosurg 2005; 41: 131-136.
2. Rotim K, et al: Reducing the incidence of infection in pediatric cerebrospinal fluid shunt operations. Childs Nerv Syst 1997; 13: 584-587.
3. Dallacasa P, et al: Cerebrospinal fluid shunt infections in infants. Childs Nerv Syst 1995; 11: 643-648, discussion 649.
4. Kontny U, et al: CSF shunt infections in children. Infection 1993; 21: 89-92.
5. Zafar N, et al: Improving survival of vulnerable infants increases neonatal intensive care unit nosocomial infection rate. Arch Pediatr Adolesc Med 2001; 155: 1098-1104.
6. Baumeister FAM, Hofer M, Egger J: Progressive posthämorrhagische Ventrikelerweiterung der Frühgeborenen. Monatsschr Kinderheilkd 2000; 148: 1072-1077.
7. Shah SS, Smith MJ, Zaoutis TE: Device-related infections in children. Pediatr Clin North Am 2005; 52: 1189-1208, x.
8. Kestle J, et al: Long-term follow-up data from the Shunt Design Trial. Pediatr Neurosurg 2000; 33: 230-236.
9. Pollack IF, Albright AL, Adelson PD: A randomized, controlled study of a programmable shunt valve versus a conventional valve for patients with hydrocephalus. Hakim- Medos Investigator Group. Neurosurgery 1999; 45: 1399-1408, discussion 1408-1411.
10. Rowin ME, Patel VV, Christenson JC: Pediatric intensive care unit nosocomial infections: epidemiology, sources and solutions. Crit Care Clin 2003; 19: 473-487.
11. Key CB, Rothrock SG, Falk JL: Cerebrospinal fluid shunt complications: an emergency medicine perspective. Pediatr Emerg Care 1995; 11: 265-273.
12. Anderson EJ, Yogev R: A rational approach to the management of ventricular shunt infections. Pediatr Infect Dis J 2005; 24: 557-558.
13. Choux M, et al: Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992; 77: 875-880.
14. Albright AL, et al: Outcome data and analysis in pediatric neurosurgery. Neurosurgery 1999; 45: 101-106.
15. Pople IK: Hydrocephalus and shunts: what the neurologist should know. J Neurol Neurosurg Psychiatry 2002; 73(suppl 1):i17-i22.
16. Pople IK, Bayston R, Hayward RD: Infection of cerebrospinal fluid shunts in infants: a study of etiological factors. J Neurosurg 1992; 77: 29-36.
17. Davis SE, et al: Does age or other factors influence the incidence of ventriculoperitoneal shunt infections? Pediatr Neurosurg 1999; 30: 253-257.
18. Kulkarni AV, Drake JM, Lamberti-Pasculli M: Cerebrospinal fluid shunt infection: a prospective study of risk factors. J Neurosurg 2001; 94: 195-201. (Pubitemid 32799678)
19. Mancao M, et al: Cerebrospinal fluid shunt infections in infants and children in Mobile, Alabama. Acta Paediatr 1998; 87: 667-670.
20. Odio C, McCracken GH Jr, Nelson JD: CSF shunt infections in pediatrics: a seven-year experience. Am J Dis Child 1984; 138: 1103-1108.
21. Ronan A, Hogg GG, Klug GL: Cerebrospinal fluid shunt infections in children. Pediatr Infect Dis J 1995; 14: 782-786.
22. Duhaime AC: Evaluation and management of shunt infections in children with hydrocephalus. Clin Pediatr (Phila) 2006; 45: 705-713.
23. Haines SJ: Shunt infection. J Neurosurg 2007; 106(suppl 1):13-14, discussion 14.
24. James HE, et al: Ventriculoperitoneal shunts in high risk newborns weighing under 2,0 grams: a clinical report. Neurosurgery 1984; 15: 198-202.
25. McGirt MJ, et al: Risk factors for pediatric ventriculoperitoneal shunt infection and predictors of infectious pathogens. Clin Infect Dis 2003; 36: 858-862.
26. Borgbjerg BM, et al: Risk of infection after cerebrospinal fluid shunt: an analysis of 884 first-time shunts. Acta Neurochir (Wien) 1995; 136: 1-7.
27. Caldarelli M, di Rocco C, la Marca F: Shunt complications in the first postoperative year in children with meningomyelocele. Childs Nerv Syst 1996; 12: 748-754.
28. Gamache FW Jr: Treatment of hydrocephalus in patients with meningomyelocele or encephalocele: a recent series. Childs Nerv Syst 1995; 11: 487-488.
29. Drake JM: Does double gloving prevent cerebrospinal fluid shunt infection? J Neurosurg 2006; 104(suppl 1):3-4, discussion 4.
30. Tulipan N, Cleves MA: Effect of an intraoperative double-gloving strategy on the incidence of cerebrospinal fluid shunt infection. J Neurosurg 2006; 104(suppl 1):5-8.
31. Cochrane DD, Kestle J: Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001. Eur J Pediatr Surg 2002; 12(suppl 1):S6-S11.
32. Pattavilakom A, et al: Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study. J Clin Neurosci 2007; 14: 526-531.
33. McClinton D, Carraccio C, Englander R: Predictors of ventriculoperitoneal shunt pathology. Pediatr Infect Dis J 2001; 20: 593-597.
34. Tunkel AR, et al: Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004; 39: 1267-1284.
35. Kommission für Krankenhaushygiene und Infektionsprävention, Ausbruchsmanagement und strukturiertes Vorgehen bei gehäuftem Auftreten nosokomialer Infektionen: Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert-Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2002; 45: 180-186.
36. Younger JJ, et al: Coagulase-negative staphylococci isolated from cerebrospinal fluid shunts: importance of slime production, species identification, and shunt removal to clinical outcome. J Infect Dis 1987; 156: 548-554.
37. Craft A, Finer N: Nosocomial coagulasenegative staphylococcal (CoNS) catheter-related sepsis in preterm infants: definition, diagnosis, prophylaxis, and prevention. J Perinatol 2001; 21: 186-192.
38. Guggenbichler JP, et al: In vitro and in vivo effect of antibiotics on catheters colonized by staphylococci. Eur J Clin Microbiol Infect Dis 1992; 11: 408-415.
39. Stamos JK, Kaufman BA, Yogev R: Ventriculoperitoneal shunt infections with Gramnegative bacteria. Neurosurgery 1993; 33: 858-862.
40. Shen MC, et al: Liver abscess caused by an infected ventriculoperitoneal shunt. J Formos Med Assoc 2003; 102: 113-116.
41. Tchirkow G, Verhagen AD: Bacterial peritonitis in patients with ventriculoperitoneal shunt. J Pediatr Surg 1979; 14: 182-184.
42. Brook I: Microbiology and management of post-surgical wounds infection in children. Pediatr Rehabil 2002; 5: 171-176. (Pubitemid 36069964)
43. Brook I: Meningitis and shunt infection caused by anaerobic bacteria in children. Pediatr Neurol 2002; 26: 99-105. (Pubitemid 34207807)
44. Kelly ME, et al: Propionibacterium acnes infections after cranial neurosurgery. Can J Neurol Sci 2006; 33: 292-295.
45. Chiou CC, et al: Fungal infection of ventriculoperitoneal shunts in children. Clin Infect Dis 1994; 19: 1049-1053.
46. Baird C, O'Connor D, Pittman T: Late shunt infections. Pediatr Neurosurg 1999; 31: 269-273.
47. Walters BC, et al: Cerebrospinal fluid shunt infection. Influences on initial management and subsequent outcome. J Neurosurg 1984; 60: 1014-1021.
48. Johnson DL, Conry J, O'Donnell R: Epileptic seizure as a sign of cerebrospinal fluid shunt malfunction. Pediatr Neurosurg 1996; 24: 223-227, discussion 227-228.
49. Klepper J, et al: Epilepsy in shunt-treated hydrocephalus. Dev Med Child Neurol 1998; 40: 731-736.
50. Gottfried ON, et al: Distal ventriculoperitoneal shunt failure secondary to Clostridium difficile colitis. Acta Neurochir (Wien) 2005; 147: 335-338, discussion 338.
51. Mobley LW 3rd, Doran SE, Hellbusch LC: Abdominal pseudocyst: predisposing factors and treatment algorithm. Pediatr Neurosurg 2005; 41: 77-83.
52. Roitberg BZ, Tomita T, McLone DG: Abdominal cerebrospinal fluid pseudocyst: a complication of ventriculoperitoneal shunt in children. Pediatr Neurosurg 1998; 29: 267-273.
53. Rush DS, et al: Ventricular sepsis and abdominally related complications in children with cerebrospinal fluid shunts. Surgery 1985; 97: 420-427.
54. Pittman T, et al: The risk of abdominal operations in children with ventriculoperitoneal shunts. J Pediatr Surg 1992; 27: 1051-1053.
55. Wang KW, et al: Infection of cerebrospinal fluid shunts: causative pathogens, clinical features, and outcomes. Jpn J Infect Dis 2004; 57: 44-48.
56. Buck D, et al: Ventricular shunts and the prevalence of sensitization and clinically relevant allergy to latex in patients with spina bifida. Pediatr Allergy Immunol 2000; 11: 111-115.
57. Niggemann B, et al: Latex allergy as a cause of eosinophilia in cerebrospinal fluid in a child with a ventricular shunt. J Allergy Clin Immunol 1997; 100: 849-850.
58. Tanaka T, et al: A case of cerebrospinal fluid eosinophilia associated with shunt malfunction. Pediatr Neurosurg 1999; 30: 6-10.
59. Lan CC, et al: Early diagnosis of ventriculoperitoneal shunt infections and malfunctions in children with hydrocephalus. J Microbiol Immunol Infect 2003; 36: 47-50.
60. Tatara R, Imai H: Serum C-reactive protein in the differential diagnosis of childhood meningitis. Pediatr Int 2000; 42: 541-546.
61. Sormunen P, et al: C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr 1999; 134: 725-729.
62. Fida NM, Al-Mughales J, Farouq M: Interleukin- 1alpha, interleukin-6 and tumor necrosis factor-alpha levels in children with sepsis and meningitis. Pediatr Int 2006; 48: 118-124.
63. Mukai AO, et al: TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol 2006; 34: 25-29.
64. Yilmaz E, et al: Interleukin-8 levels in children with bacterial, tuberculous and aseptic meningitis. Indian J Pediatr 2002; 69: 219-221.
65. Dubos F, et al: Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 2006; 149: 72-76.
66. Myers MG, Schoenbaum SC: Shunt fluid aspiration: an adjunct in the diagnosis of cerebrospinal fluid shunt infection. Am J Dis Child 1975; 129: 220-222.
67. Adler H, Widmer A, Frei R: Emergence of a teicoplanin-resistant small colony variant of Staphylococcus epidermidis during vancomycin therapy. Eur J Clin Microbiol Infect Dis 2003; 22: 746-748.
68. Vanaclocha V, Saiz-Sapena N, Leiva J: Shunt malfunction in relation to shunt infection. Acta Neurochir (Wien) 1996; 138: 829-834.
69. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut: Händehygiene: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2000; 43: 230-233.
70. Fisher M: Prevention and management of pediatric catheter-related infections. Semin Pediatr Infect Dis 2001; 12: 130-137.
71. Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut: Prävention postoperativer Infektionen im Operationsgebiet: Empfehlungen der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert-Koch-Institut. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 377-393.
72. Kulkarni AV, et al: Repeat cerebrospinal fluid shunt infection in children. Pediatr Neurosurg 2001; 35: 66-71.
73. Kanev PM, Sheehan JM: Reflections on shunt infection. Pediatr Neurosurg 2003; 39: 285-290.
74. Thompson DN, Hartley JC, Hayward RD: Shunt infection: is there a near-miss scenario? J Neurosurg 2007; 106(suppl 1):15-19.
75. Dettenkofer M, et al: The practice of perioperative antibiotic prophylaxis in eight German hospitals. Infection 2002; 30: 164-167.
76. Ruef C: Perioperative antibiotic prophylaxis: still room for improvement. Infection 2002; 30: 117.
77. Ebner W, et al: Evidence-based recommendations for perioperative antibiotic prophylaxis (in German). Chirurg 2000; 71: 912-917.
78. Bratzler DW, Houck PM: Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189: 395-404.
79. Biyani N, et al: Prophylactic antibiotics in pediatric shunt surgery. Childs Nerv Syst 2006; 22: 1465-1471.
80. Haines SJ, Walters BC: Antibiotic prophylaxis for cerebrospinal fluid shunts: a metaanalysis. Neurosurgery 1994; 34: 87-92.
81. Frank AL, et al: Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J 2002; 21: 530-534.
82. Ladhani S, Garbash M: Staphylococcal skin infections in children: rational drug therapy recommendations. Paediatr Drugs 2005; 7: 77-102.
83. Ragel BT, Browd SR, Schmidt RH: Surgical shunt infection: significant reduction when using intraventricular and systemic antibiotic agents. J Neurosurg 2006; 105: 242-247.
84. Shah SS, et al: Vancomycin use in pediatric neurosurgery patients. Am J Infect Control 1999; 27: 482-487.
85. Fan-Havard P, et al: Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement. Chemotherapy 1990; 36: 103-108. (Pubitemid 20079273)
86. Klotz M, et al: Possible risk for re-colonization with methicillin-resistant Staphylococcus aureus (MRSA) by faecal transmission. Int J Hyg Environ Health 2005; 208: 401-405.
87. Gerber SI, et al: Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27: 139-145.
88. Simon A, et al: Methicillin-resistente Staphylococcus aureus (MRSA): Übersicht zu Bedeutung und Management in der stationären Kinderheilkunde. Hyg Med 2003; 28: 62-74.
89. Ratilal B, Costa J, Sampaio C: Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts. Cochrane Database Syst Rev 2006; 3:CD005365.
90. Hampl JA, et al: Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections. Infection 2003; 31: 109-111.
91. Sciubba DM, et al: Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus. J Neurosurg 2005; 103 (suppl 2):131-136.
92. Govender ST, Nathoo N, van Dellen JR: Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus. J Neurosurg 2003; 99: 831-839.
93. Kan P, Kestle J: Lack of efficacy of antibiotic- impregnated shunt systems in preventing shunt infections in children. Childs Nerv Syst 2007; 23: 773-777.
94. Aryan HE, et al: Initial experience with antibiotic- impregnated silicone catheters for shunting of cerebrospinal fluid in children. Childs Nerv Syst 2005; 21: 56-61.
95. Whitehead WE, Kestle JR: The treatment of cerebrospinal fluid shunt infections. Results from a practice survey of the American Society of Pediatric Neurosurgeons. Pediatr Neurosurg 2001; 35: 205-210.
96. Morissette I, Gourdeau M, Francoeur J: CSF shunt infections: a fifteen-year experience with emphasis on management and outcome. Can J Neurol Sci 1993; 20: 118-122.
97. Schreffler RT, Schreffler AJ, Wittler RR: Treatment of cerebrospinal fluid shunt infections: a decision analysis. Pediatr Infect Dis J 2002; 21: 632-636.
98. National Nosocomial Infections Surveillance System: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
99. Cantu TG, Yamanaka-Yuen NA, Lietman PS: Serum vancomycin concentrations: reappraisal of their clinical value. Clin Infect Dis 1994; 18: 533-543.
100. Lutsar I, McCracken GH Jr, Friedland IR: Antibiotic pharmacodynamics in cerebrospinal fluid. Clin Infect Dis 1998; 27: 1117- 1127, quiz 1128-1129.
101. Craig WA: Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infect Dis Clin North Am 2003; 17: 479-501.
102. Sidi V, et al: Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and Gram-positive bacteremia. J Chemother 2000; 12: 326-331.
103. Wood M: Comparative safety of teicoplanin and vancomycin. J Chemother 2000; 12(suppl 5):21-25.
104. Scholz H, et al: Parenterale Antibiotikatherapie bei Kindern und Jugendlichen: Empfehlungen der Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. Chemother J 2004; 13: 115-133.
105. Blumer JL, Reed MD, Knupp C: Review of the pharmacokinetics of cefepime in children. Pediatr Infect Dis J 2001; 20: 337-342.
106. Rhoney DH, et al: Disposition of cefepime in the central nervous system of patients with external ventricular drains. Pharmacotherapy 2003; 23: 310-314.
107. Saez-Llorens X, et al: Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother 1995; 39: 937-940.
108. Saez-Llorens X, O'Ryan M: Cefepime in the empiric treatment of meningitis in children. Pediatr Infect Dis J 2001; 20: 356-361.
109. Myrianthefs P, et al: Serum and cerebros pinal fluid concentrations of linezolid in neurosurgical patients. Antimicrob Agents Chemother 2006; 50: 3971-3976.
110. Brown EM, Edwards RJ, Pople IK: Conservative management of patients with cerebrospinal fluid shunt infections. Neurosurgery 2006; 58: 657-665, discussion 657-665.
111. Cruciani M, et al: Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections. Clin Infect Dis 1992; 15: 285-289.
112. Venditti M, et al: Intraventricular administration of teicoplanin in shunt-associated ventriculitis caused by methicillin-resistant Staphylococcus aureus . J Antimicrob Chemother 1988; 21: 513-515.
113. Kestle JR, et al: Management of shunt infections: a multicenter pilot study. J Neurosurg 2006; 105(suppl 3):177-181.
114. Plosker GL, Figgitt DP: Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections. Pharmacoeconomics 2005; 23: 945-964.
115. Baysallar M, et al: A case of ventricular drainage infection with a rare pathogen in cerebrospinal fluid: vancomycin-resistant Enterococcus faecium . Microb Drug Resist 2006; 12: 59-62.
116. Beer R, et al: Pharmacokinetics of intravenous linezolid in cerebrospinal fluid and plasma in neurointensive care patients with staphylococcal ventriculitis associated with external ventricular drains. Antimicrob Agents Chemother 2007; 51: 379-382.
117. Boak LM, et al: Successful treatment and cerebrospinal fluid penetration of oral linezolid in a patient with coagulase-negative Staphylococcus ventriculitis. Ann Pharmacother 2006; 40: 1451-1455.
118. Malacarne P, et al: Linezolid cerebrospinal fluid concentration in central nervous system infection. J Chemother 2007; 19: 90-93.
119. Murphy K, Bradley J, James HE: The treatment of Candida albicans shunt infections. Childs Nerv Syst 2000; 16: 4-7.
120. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK: Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.
121. Bruinsma N, et al: Subcutaneous ventricular catheter reservoir and ventriculoperitoneal drain-related infections in preterm infants and young children. Clin Microbiol Infect 2000; 6: 202-206.
122. Braga MH, et al: Early shunt complications in 46 children with hydrocephalus. Arq Neuropsiquiatr 2009; 67: 273-277.
123. Lima MM, Pereira CU, Silva AM: Ventriculoperitoneal shunt infections in children and adolescents with hydrocephalus (in Portuguese). Arq Neuropsiquiatr 2007; 65: 118-123.
124. Enger PO, et al: Shunt revisions in children: can they be avoided? Experiences from a population-based study. Pediatr Neurosurg 2005; 41: 300-304